Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - inactivated erysipelotrix rhusiopathiae , porcine parvovirus (ppv) , leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae , leptospira interrogans ser. australis , leptospira interrogans ser. grippotyphosa , leptospira interrogans ser. pomona , leptospira interrogans ser. tarassovi vaccine (vet.) - suspension for injection (im) - formulation: each dose contains: erysipelothrix rhusiopathiae (serotype 2 strain) .......... >1 ppd porcine parvovirus (014 strain) .............. >65 u/ml l. interrogans serogroup canicola serovar portland-vere (ca-12-000 strain) ...... >1408 u/ml l. interrogans serogroup icterohaemorrhagiae serovar copenhagi (ic-02-001 strain).............. >105 u/ml l. interrogans serogroup australis serovar bratislava (as-05-073 strain) .........>655 u/ml l. interrogans serogroup grippotyphosa serovar dadas (gr-01-005 strain) ............ >324 u/ml l. interrogans serogroup pomona serovar pomona (po-01-000 strain) ............> 83 u/ml l. interrogans serogroup tarassovi serovar gatuni (s1148/02 strain) ......>138 u/ml eid - embryo infective dose

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - e.rhusiopathiae strain m2; porcine parvo virus; leptospira canicola; leptospira icterohaemorrhagiae; leptospira australis; leptospira grippotyphosa; leptospira pomona; leptospira tarassovi - suspension for injection - . - porcine parvovirus + erysipelothrix + leptospira

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet international bv - e.rhusiopathiae strain m2, porcine parvo virus, leptospira canicola, leptospira icterohaemorrhagiae, leptospira australis, leptospira grippotyphosa, leptospira pomona, leptospira tarassovi - suspension for injection - inactivated porcine parvovirus vaccine + inactivated erysipelothrix vaccine + inactivated leptospira - porcine - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet international bv - e.rhusiopathiae strain m2; porcine parvo virus; leptospira canicola; leptospira icterohaemorrhagiae; leptospira australis; leptospira grippotyphosa; leptospira pomona; leptospira tarassovi - suspension for injection - . - porcine parvovirus + erysipelothrix + leptospira - pigs - immunological - inactivated vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - e.rhusiopathiae - vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - erysipelothrix rhusiopathiae; thiomersal - parenteral liquid/solution/suspension - erysipelothrix rhusiopathiae vaccine-general active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - lamb | pigs | sheep | boar | ewe | gilt | hogget | lamb | ovine | piglet | ram | sow | swine | weaner | wether - erysipelas - swine | erysipelothrix arthritis | vaccine | equine rotavirus | swine erysipelas

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - erysipelothrix rhusiopathiae, strain r32e11 (inactivated) - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by erysipelothrix rhusiopathiae, serotype 1 and serotype 2.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - porcine parvovirus, strain nadl-2 and erysipelothrix rhusiopathiae, strain r32e11 (inactivated) - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs - for the active immunisation of female pigs for the protection of progeny against transplacental infection caused by porcine parvovirus.for the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by erysipelothrix rhusiopathiae, serotype 1 and serotype 2.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - erysipelothrix rhusiopathiae - 3050 - unknown - erysipelothrix rhusiopathiae - 3050 vaccine active 0.0 - active constituent

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated porcine parvovirus , erysipelothrix rhusiopathiae , leptospira interrogans serovar icterohaemorrhagiae , leptospira interrogans serovar canicola , leptospira interrogans serovar pomona , leptospira interrogans serovar hardjo , leptospira interrogans serovar grippotyphosa , leptospira interrogans serovar bratislava vaccine (vet.) - suspension for injection (im) - each 2ml (dose) contains porcine parvovirus (nadl-2 strain) >1.15* eryspelothrix rhusiopathiae (r32e11 strain)>3.34** leptospira interrogans serovar icterohaemorrhagiae->108mo leptospira interrogans serovar canicola-->108mo leptospira interrogans serovar pomona-->108mo leptospira interrogans serovar hardjo-->108mo leptospira interrogans serovar grippotyphosa-->108mo leptospira interrogans serovar bratislava-->108mo *rp, relative potency (elisa) **ies. (inhibition elisa 50%) mo - microorganismus